SlideShare a Scribd company logo
1 of 25
Randox Quality ControlThird Party Controls
Who are we?
• Leading primary manufacturer of true third party control materials supplying over 60,000 laboratories worldwide
• 3rd largest manufacturer of QC and calibrators globally
• Flexible product range covering over 350 routine and esoteric analytes
• World’s leading supplier of QC material to PT schemes globally
• World’s largest PT provider globally
• Choice of liquid or lyophilized controls depending on customer requirements
• World’s largest manufacturer of customized quality controls
• Clinical Chemistry
• Immunoassay
• Immunology/Proteins
• Cardiac Markers
• Haematology
• Coagulation
• Urine Chemistry
• Drugs of Abuse
• Therapeutic Drugs
• Tumour Markers
• Maternal Screening
• Lipids
• HbA1c
• Blood Gas
• Speciality/Research
• POC
The Acusera QC Range
Key Benefits
• Cost Effective
― Consolidation
― Clinically significant levels
― Reduced waste
• High Quality
― Accurate
― True third party
― Commutable
― Consistent
― Material and Manufacturing
• Flexibility
― Extensive analyte menu
― Variety of formats
Cost Effective + High Quality + Flexibility = Increased
Efficiency and Accuracy
Cost Effective – Consolidation
• Where previously large multifunctional laboratories may have had to routinely run >30 controls it is now possible to
produce highly accurate results using 10 or less Randox controls
• Our unique combination of analytes allows for effective test menu consolidation without compromising on quality
• Our range of multi-analyte controls cover up to 100 analytes in a single vial
• By reducing the number of individual controls used you can significantly increase productivity and reduce costs while
benefiting from:
― Fewer orders to manage
― Reduced preparation time
― Minimal sample handling
― Fewer controls to monitor and track expiry dates
Less is More!
Consolidation with Immunoassay Premium Plus
• The Randox Immunoassay Premium
plus control covers up to 54 analytes in
total
- Routine tumour markers CA15-3, CA19-9
and CA125 not present in the competitor
IA controls
- Clinically relevant levels of TSH, Ferritin
and Vitamin B12 replacing the need for a
separate Anaemia control
- Extensive range of therapeutic drugs
- Additional benefits include; 100% human
serum, Assayed target values
Labs may be using 4 or more competitor
controls to cover what is included in just
1 Randox control
Consolidation with Liquid Assayed Chemistry Premium Plus
• Combines 99 analytes including lipids,
proteins, routine immunoassay, cardiac
markers, therapeutic drugs and
electrophoresis
• Eliminates the need for six or more
individual controls
Labs may be using 6 or more competitor
controls to cover what is included in just
1 Randox control
Cost Effective – Consolidation
• Randox controls will cover clinically significant concentrations
―Many analytes present at clinical decision levels
―Eliminates the need for additional low/high level controls at extra expense
―Recommended by ISO 15189
• Many competitors market separate controls for low analyte levels
―This not only increases preparation time but can have significant cost implications
“The laboratory should choose concentrations of control materials, wherever possible, especially at or near clinical decision values ,
which ensure the validity of decisions made”
ISO 15189 5.6.2.2
Consolidation – Clinically Relevant Levels
Comparison of the Randox Immunoassay
Premium Plus and a competitors Immunoassay
control shows that:
• Competitor 1 does not cover the 0.1 uU/ml
decision level for TSH. Values are within the
normal range 0.4-0.5
• Competitor 1 does not cover the 190pmol/l
decision level for Vitamin B12
• Ferritin levels in the Competitor 1 level 1
control are too high
• Competitor 1 does not cover the 3mIU/l
decision level for insulin
Consolidation – Clinically Relevant Levels
The Liquid Chemistry
Premium Plus control
contains high levels of
CRP and other
proteins eliminating
the need for a
separate protein
control.
Consolidation – Clinically Relevant Levels
• New high sensitivity troponin assays allow for earlier detection of
troponin in the blood allowing for early rule out
• Demand for lower troponin levels to ensure accurate instrument
performance at such highly sensitive levels
Randox L1 Competitor L1
Analyte Units 3833CK 3909CK 3910CK Mean Analyte Units 29831 29841 29851Mean
Troponin I ng/ml 0.089 0.03 0.086 0.07Troponin I ng/ml 1.21 1.76 0.68 1.22
Cost Effective – Consolidation
Competitor Randox
Chemistry Control Assayed Chemistry Premium Plus
Immunology Control
Competitor Randox
Immunoassay Control Immunoassay Premium Plus
Tumour Marker Control 1 Immunoassay Speciality
Tumour Marker Control 2
Speciality Control
Vitamin D Control
Anti-TPO Control
Low Testosterone Control
9 competitor controls consolidated to just 3 Randox controls
Cost Effective – Consolidation
Competitor Controls Randox Controls
Chemistry Control Level 1 Assayed Chemistry Premium Plus Control L2
Chemistry Control Level 2 Assayed Chemistry Premium Plus Control L3
Immunology Control Level 1 Custom RF + CRP Control
Immunology Control Level 3
Bile Acids Control Level 1
Bile Acids Control Level 2
Lipid Control Level 1
Lipid Control Level 3
Troponin Level 1
Troponin Level 2
Competitor Controls Randox Controls
Anaemia Control Level 1 Immunoassay Premium Plus L1
Anaemia Control Level 2 Immunoassay Premium Plus L3
Tumour Marker Control Level 1
Tumour Marker Control Level 2
TDM Control Level 1
TDM Control Level 2
16 competitor controls consolidated to just 5 Randox controls
High Quality
• Accurate target values
― Unique value assignment process employing over 40,000 independent labs
― Ensures availability of data for multiple methods and instruments
― Statistically valid
― Unlike some competitor controls target values won’t shift throughout the shelf life
• True third party
― Deliver unbiased performance assessment
― Availability of target values for a wide range of instruments
― Eliminates the need for multiple instrument specific controls
― Recommended by ISO 15189
• Commutable
― QC samples will behave in the same manner as the patient sample
― 100% human samples for immunoassay methods eliminating QC shifts when reagent batch is changed
― Vital when validating new batches of reagent
― Ensures minimal lot to lot variation
― Recommended by ISO 15189
Ensure complete confidence in routine testing
Benefits of commutability
• Most labs will be experiencing shifts in QC target values when they change
batch of reagent – especially with Immunoassay tests
• By using a commutable control laboratories could
- Reduce the need to re-assign QC target values when reagent batch is used
- Reduce labour
- Reduce costs of QC
- Reduce reagent wastage
- Reduce troubleshooting
- Improve confidence that test system is performing accurately
- Meet accreditation and regulatory requirements
High Quality
• Consistent from lot to lot
― Possible due to our superior manufacturing processes and high quality base material
― Target values will not differ significantly between lots
― Stability claims will remain consistent from lot to lot unlike some competitors
• Stability
― Shelf life of up to 4 years for lyophilised controls and 2 years for liquid controls
― Ensures continuity of lot supply and reduces costly lot changes and validation studies
― Laboratories can use the same lot of control for longer
― The excellent working stability of our controls will also help to reduce costs and minimise waste
• Traceability
― Traceable to international reference materials
Ultimately ensures accurate test results with a reduction in costs and time due to fewer re-runs
Gain and Maintain ISO Accreditation
ISO 15189:2012 Requirements
• Commutable controls (Acusera)
― “The laboratory shall use quality control materials that react to the examining system in a manner as close as possible to patient samples”
• True third party controls (Acusera)
― “Use of independent third party control materials should be considered, either instead of, or in addition to, any control materials supplied by the
reagent or instrument manufacturer”
• Clinically significant concentrations (Acusera)
― “The laboratory should choose concentrations of control materials, wherever possible, especially at or near clinical decision values , which ensure the
validity of decisions made”
• Interlaboratory data management (Acusera 24.7)
― “The laboratory shall have a procedure to prevent the release of patient results in the event of quality control failure. When the quality control rules
are violated ………the results shall be rejected and relevant patient samples re-examined”
• External Quality Assessment (RIQAS)
― “The laboratory shall participate in an interlaboratory comparison programme(s) (such as an external quality assessment programme or proficiency
testing programme)”
Flexibility
• Extensive analyte menu covering over 350 routine and specialised
parameters
• Choice of
―Assayed/Unassayed controls
―Liquid/Lyophilised controls
―Human/Bovine controls
Assayed Chemistry Premium Plus
• Method and instrument specific target values available for 70 analytes
― Includes proteins, immunoassays, lipids, TDMs, cardiac markers, electrophoresis
― Reduces the need for multiple control products
• Clinically significant osmolality values
― ~300 mOsm/kg in level 2 and ~ 370 mOSm/kg in level 3
― Eliminates the need for additional control material
• No added preservatives / stabilisers
• Excellent working stability
― 7 days at 2oC to 8oC, extended to 4 weeks when stored at -20oC
― Minimises waste and reduces cost
• Lyophilised for extended shelf life
― 4 year shelf life means the same lot can be used for longer
Immunoassay Premium Plus
• Unique 100% human serum matrix
― The material behaves just like a sample patient
― No need to re-assign QC values when reagent batch is changed
• Instrument specific target values for 54 analytes
― Including Tumour Markers, Hormones, Therapeutic Drugs and Vitamin D
― Significantly reduces the number of individual immunoassay controls required
• Three clinically significant levels available
― Low levels of TSH, Ferritin and Vitamin B12
― No need to purchase an additional low level control at extra expense
• Excellent working stability
― 7 days at 2oC to 8oC, extended to 4 weeks when stored at -20oC
― Minimises waste and reduces cost
Specific Protein Control
• Contains assayed target values and ranges for 27 serum proteins; including AFP,
RF, Free Kappa Light Chain and Free Lambda Light Chain
• Liquid ready-to-use requiring no preparation
• Open vial stability of 30 days at 2oC to 8oC for all analytes minimises waste and
helps to keep costs low
• This unique combination of analytes allows for effective consolidation and
significant cost savings
Liquid Cardiac Control
• Contains target values for an impressive 8 different analytes, including Troponin I,
Troponin T and D-dimer
• Cut off levels for Troponin I and T are in line with internationally recommended
levels
• No need to purchase a separate control for D-dimer or separate low level controls
for Troponin I and T
• Liquid ready-to-use requiring no preparation
• Open vial stability of 30 days at 2oC to 8oC for all analytes keeps waste to a
minimum
Summary
• Most accurate controls available
― Target values based on data from thousands of independent labs
• Most consistent material
― Minimal variation in analyte concentration between lots
• Unrivalled stability
― Will meet and often exceed stability claims
• Highest quality material
― No added preservatives/stabilisers in our lyophilised material
― Most commutable material
• True third party controls
― Provide an unbiased, independent assessment of performance
• Consolidation
― Reduce the number of individual controls required
Thank You

More Related Content

What's hot

Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationSHIVANEE VYAS
 
Qualification of Analytical Equipments
Qualification of Analytical EquipmentsQualification of Analytical Equipments
Qualification of Analytical EquipmentsDhawal_Raghuvanshi
 
Method validation
Method validationMethod validation
Method validationDrHinal
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party ControlsRandox
 
Biological variation as an uncertainty component
Biological variation as an uncertainty componentBiological variation as an uncertainty component
Biological variation as an uncertainty componentGH Yeoh
 
Introduction to proficiency testing
Introduction to proficiency testingIntroduction to proficiency testing
Introduction to proficiency testingSoils FAO-GSP
 
Overview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxOverview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxDipesh Tamrakar
 
Validation of Analytical and Bioanalytical methods
Validation of Analytical and Bioanalytical methodsValidation of Analytical and Bioanalytical methods
Validation of Analytical and Bioanalytical methodssarikakkadam
 
Method validation and Verification .pdf
Method validation and Verification .pdfMethod validation and Verification .pdf
Method validation and Verification .pdfMMathaiyanMani
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptxBholakant raut
 
Laboratory Method Verification, March 2017
Laboratory Method Verification, March 2017Laboratory Method Verification, March 2017
Laboratory Method Verification, March 2017Ola Elgaddar
 
Quality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.pptQuality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.pptSUNILDhatwalia1
 
Stability Testing of Phytopharmaceuticals
Stability Testing of PhytopharmaceuticalsStability Testing of Phytopharmaceuticals
Stability Testing of PhytopharmaceuticalsManjusha Kondepudi
 
RIQAS External Quality Assessment for Medical Laboratories
RIQAS External Quality Assessment for Medical Laboratories RIQAS External Quality Assessment for Medical Laboratories
RIQAS External Quality Assessment for Medical Laboratories Randox
 
Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...ShameerAbid
 
Clinical lab-method validation.ppt
Clinical lab-method validation.pptClinical lab-method validation.ppt
Clinical lab-method validation.pptDovMurtazaHashmi
 
The Role of Proficiency Testing in Laboratory Quality Assurance
The Role of Proficiency Testing in Laboratory Quality AssuranceThe Role of Proficiency Testing in Laboratory Quality Assurance
The Role of Proficiency Testing in Laboratory Quality AssurancePECB
 

What's hot (20)

Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Qualification of Analytical Equipments
Qualification of Analytical EquipmentsQualification of Analytical Equipments
Qualification of Analytical Equipments
 
Method validation
Method validationMethod validation
Method validation
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party Controls
 
Biological variation as an uncertainty component
Biological variation as an uncertainty componentBiological variation as an uncertainty component
Biological variation as an uncertainty component
 
Introduction to proficiency testing
Introduction to proficiency testingIntroduction to proficiency testing
Introduction to proficiency testing
 
Calibration
CalibrationCalibration
Calibration
 
Overview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxOverview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptx
 
Computer system validations
Computer system validationsComputer system validations
Computer system validations
 
Validation of Analytical and Bioanalytical methods
Validation of Analytical and Bioanalytical methodsValidation of Analytical and Bioanalytical methods
Validation of Analytical and Bioanalytical methods
 
Method validation and Verification .pdf
Method validation and Verification .pdfMethod validation and Verification .pdf
Method validation and Verification .pdf
 
Analytical validation
Analytical validationAnalytical validation
Analytical validation
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
 
Laboratory Method Verification, March 2017
Laboratory Method Verification, March 2017Laboratory Method Verification, March 2017
Laboratory Method Verification, March 2017
 
Quality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.pptQuality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.ppt
 
Stability Testing of Phytopharmaceuticals
Stability Testing of PhytopharmaceuticalsStability Testing of Phytopharmaceuticals
Stability Testing of Phytopharmaceuticals
 
RIQAS External Quality Assessment for Medical Laboratories
RIQAS External Quality Assessment for Medical Laboratories RIQAS External Quality Assessment for Medical Laboratories
RIQAS External Quality Assessment for Medical Laboratories
 
Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...Impurity profiling and degradent characterization {presented by shameer m.pha...
Impurity profiling and degradent characterization {presented by shameer m.pha...
 
Clinical lab-method validation.ppt
Clinical lab-method validation.pptClinical lab-method validation.ppt
Clinical lab-method validation.ppt
 
The Role of Proficiency Testing in Laboratory Quality Assurance
The Role of Proficiency Testing in Laboratory Quality AssuranceThe Role of Proficiency Testing in Laboratory Quality Assurance
The Role of Proficiency Testing in Laboratory Quality Assurance
 

Similar to Acusera Third Party Controls

LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17Randox
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratorysanarehman8159
 
Master Quality control for clinical laboratories.pptx
Master Quality control for clinical laboratories.pptxMaster Quality control for clinical laboratories.pptx
Master Quality control for clinical laboratories.pptxJULIUSMATERN
 
Guidelines regarding point of care testing
Guidelines regarding point of care testingGuidelines regarding point of care testing
Guidelines regarding point of care testingjdyjdo
 
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdfaibn1
 
Control of analytical quality using stable control materials postgrad
Control of analytical quality using stable control materials postgradControl of analytical quality using stable control materials postgrad
Control of analytical quality using stable control materials postgradMedhatEldeeb2
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validationRam Kumar
 
(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptxDr.Rajeev Ranjan
 
What format is best for your laboratory
What format is best for your laboratoryWhat format is best for your laboratory
What format is best for your laboratoryRandox
 
Pharmaceutical Quality Control Laboratory.pptx..........pptx
Pharmaceutical Quality Control Laboratory.pptx..........pptxPharmaceutical Quality Control Laboratory.pptx..........pptx
Pharmaceutical Quality Control Laboratory.pptx..........pptxNafeesaHanif1
 
Improving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - CommutabilityImproving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - CommutabilityRandox
 
Quality control-1 (1)
Quality control-1 (1)Quality control-1 (1)
Quality control-1 (1)Aychan18
 
Presentation: Bioequivalence
Presentation: BioequivalencePresentation: Bioequivalence
Presentation: BioequivalenceTGA Australia
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterParker Hannifin Corporation
 
Analytical method validation as per ich and usp
Analytical method validation as per ich and usp Analytical method validation as per ich and usp
Analytical method validation as per ich and usp shreyas B R
 
Medical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
Medical Supplies Budgeting and Consumable Price Benchmarking l MD BuylineMedical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
Medical Supplies Budgeting and Consumable Price Benchmarking l MD BuylineMD Buyline
 
Quality control of pharmaceuticals
Quality control of pharmaceuticalsQuality control of pharmaceuticals
Quality control of pharmaceuticalsSiham Abdallaha
 
Quality control of pharmaceutical products
Quality control of pharmaceutical productsQuality control of pharmaceutical products
Quality control of pharmaceutical productsSiham Abdallaha
 

Similar to Acusera Third Party Controls (20)

LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratory
 
Master Quality control for clinical laboratories.pptx
Master Quality control for clinical laboratories.pptxMaster Quality control for clinical laboratories.pptx
Master Quality control for clinical laboratories.pptx
 
Guidelines regarding point of care testing
Guidelines regarding point of care testingGuidelines regarding point of care testing
Guidelines regarding point of care testing
 
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf
1_GTobin_Qualification-Standards-Controls-Reagents_GT.pdf
 
Cap blood gas
Cap blood gasCap blood gas
Cap blood gas
 
Control of analytical quality using stable control materials postgrad
Control of analytical quality using stable control materials postgradControl of analytical quality using stable control materials postgrad
Control of analytical quality using stable control materials postgrad
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx(IQC) - Internal Quality Control.pptx
(IQC) - Internal Quality Control.pptx
 
What format is best for your laboratory
What format is best for your laboratoryWhat format is best for your laboratory
What format is best for your laboratory
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Pharmaceutical Quality Control Laboratory.pptx..........pptx
Pharmaceutical Quality Control Laboratory.pptx..........pptxPharmaceutical Quality Control Laboratory.pptx..........pptx
Pharmaceutical Quality Control Laboratory.pptx..........pptx
 
Improving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - CommutabilityImproving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - Commutability
 
Quality control-1 (1)
Quality control-1 (1)Quality control-1 (1)
Quality control-1 (1)
 
Presentation: Bioequivalence
Presentation: BioequivalencePresentation: Bioequivalence
Presentation: Bioequivalence
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
 
Analytical method validation as per ich and usp
Analytical method validation as per ich and usp Analytical method validation as per ich and usp
Analytical method validation as per ich and usp
 
Medical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
Medical Supplies Budgeting and Consumable Price Benchmarking l MD BuylineMedical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
Medical Supplies Budgeting and Consumable Price Benchmarking l MD Buyline
 
Quality control of pharmaceuticals
Quality control of pharmaceuticalsQuality control of pharmaceuticals
Quality control of pharmaceuticals
 
Quality control of pharmaceutical products
Quality control of pharmaceutical productsQuality control of pharmaceutical products
Quality control of pharmaceutical products
 

More from Randox

How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideRandox
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Randox
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Randox
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17Randox
 
Randox QC Pancake IFU
Randox QC Pancake IFURandox QC Pancake IFU
Randox QC Pancake IFURandox
 
Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & SaveRandox
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017Randox
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QCRandox
 
Designing an appropriate qc design procedure for your lab 5 mar15
Designing an appropriate qc design procedure for your lab 5 mar15Designing an appropriate qc design procedure for your lab 5 mar15
Designing an appropriate qc design procedure for your lab 5 mar15Randox
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingRandox
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rulesRandox
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CCRandox
 
QC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality ControlQC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality ControlRandox
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify PresentationRandox
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Randox
 
FOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific ProteinsFOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific ProteinsRandox
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure UncertaintyRandox
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QCRandox
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?Randox
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Randox
 

More from Randox (20)

How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational Guide
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17
 
Randox QC Pancake IFU
Randox QC Pancake IFURandox QC Pancake IFU
Randox QC Pancake IFU
 
Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & Save
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QC
 
Designing an appropriate qc design procedure for your lab 5 mar15
Designing an appropriate qc design procedure for your lab 5 mar15Designing an appropriate qc design procedure for your lab 5 mar15
Designing an appropriate qc design procedure for your lab 5 mar15
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rules
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CC
 
QC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality ControlQC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality Control
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify Presentation
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
 
FOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific ProteinsFOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific Proteins
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure Uncertainty
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QC
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
 

Recently uploaded

Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxLipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxRajendra Dev Bhatt
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...The Lifesciences Magazine
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxMumux Mirani
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Doveagatadrynko
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxShubham
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseNAGKINGRAPELLY
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingNursing education
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?HelenBevan4
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfDharma Homoeopathy
 
ILO (International Labour Organization )
ILO (International Labour Organization )ILO (International Labour Organization )
ILO (International Labour Organization )Puja Kumari
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfSasikiranMarri
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxBkGupta21
 
lupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlylupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlyRitasman Baisya
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Dr. David Greene Arizona
 
EMS Response to Terrorism involving Weapons of Mass Destruction
EMS Response to Terrorism involving Weapons of Mass DestructionEMS Response to Terrorism involving Weapons of Mass Destruction
EMS Response to Terrorism involving Weapons of Mass DestructionJannelPomida
 
MVP Health Care City of Schenectady Presentation
MVP Health Care City of Schenectady PresentationMVP Health Care City of Schenectady Presentation
MVP Health Care City of Schenectady PresentationMVP Health Care
 

Recently uploaded (20)

Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxLipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptx
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Dove
 
Kidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani HospitalKidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani Hospital
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptx
 
DELIRIUM psychiatric delirium is a organic mental disorder
DELIRIUM  psychiatric  delirium is a organic mental disorderDELIRIUM  psychiatric  delirium is a organic mental disorder
DELIRIUM psychiatric delirium is a organic mental disorder
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wise
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursing
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
 
ILO (International Labour Organization )
ILO (International Labour Organization )ILO (International Labour Organization )
ILO (International Labour Organization )
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptx
 
lupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlylupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughly
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
 
EMS Response to Terrorism involving Weapons of Mass Destruction
EMS Response to Terrorism involving Weapons of Mass DestructionEMS Response to Terrorism involving Weapons of Mass Destruction
EMS Response to Terrorism involving Weapons of Mass Destruction
 
MVP Health Care City of Schenectady Presentation
MVP Health Care City of Schenectady PresentationMVP Health Care City of Schenectady Presentation
MVP Health Care City of Schenectady Presentation
 
Coping with Childhood Cancer - How Does it Hurt Today
Coping with Childhood Cancer - How Does it Hurt TodayCoping with Childhood Cancer - How Does it Hurt Today
Coping with Childhood Cancer - How Does it Hurt Today
 

Acusera Third Party Controls

  • 2. Who are we? • Leading primary manufacturer of true third party control materials supplying over 60,000 laboratories worldwide • 3rd largest manufacturer of QC and calibrators globally • Flexible product range covering over 350 routine and esoteric analytes • World’s leading supplier of QC material to PT schemes globally • World’s largest PT provider globally • Choice of liquid or lyophilized controls depending on customer requirements • World’s largest manufacturer of customized quality controls
  • 3.
  • 4. • Clinical Chemistry • Immunoassay • Immunology/Proteins • Cardiac Markers • Haematology • Coagulation • Urine Chemistry • Drugs of Abuse • Therapeutic Drugs • Tumour Markers • Maternal Screening • Lipids • HbA1c • Blood Gas • Speciality/Research • POC The Acusera QC Range
  • 5. Key Benefits • Cost Effective ― Consolidation ― Clinically significant levels ― Reduced waste • High Quality ― Accurate ― True third party ― Commutable ― Consistent ― Material and Manufacturing • Flexibility ― Extensive analyte menu ― Variety of formats Cost Effective + High Quality + Flexibility = Increased Efficiency and Accuracy
  • 6. Cost Effective – Consolidation • Where previously large multifunctional laboratories may have had to routinely run >30 controls it is now possible to produce highly accurate results using 10 or less Randox controls • Our unique combination of analytes allows for effective test menu consolidation without compromising on quality • Our range of multi-analyte controls cover up to 100 analytes in a single vial • By reducing the number of individual controls used you can significantly increase productivity and reduce costs while benefiting from: ― Fewer orders to manage ― Reduced preparation time ― Minimal sample handling ― Fewer controls to monitor and track expiry dates Less is More!
  • 7. Consolidation with Immunoassay Premium Plus • The Randox Immunoassay Premium plus control covers up to 54 analytes in total - Routine tumour markers CA15-3, CA19-9 and CA125 not present in the competitor IA controls - Clinically relevant levels of TSH, Ferritin and Vitamin B12 replacing the need for a separate Anaemia control - Extensive range of therapeutic drugs - Additional benefits include; 100% human serum, Assayed target values Labs may be using 4 or more competitor controls to cover what is included in just 1 Randox control
  • 8. Consolidation with Liquid Assayed Chemistry Premium Plus • Combines 99 analytes including lipids, proteins, routine immunoassay, cardiac markers, therapeutic drugs and electrophoresis • Eliminates the need for six or more individual controls Labs may be using 6 or more competitor controls to cover what is included in just 1 Randox control
  • 9. Cost Effective – Consolidation • Randox controls will cover clinically significant concentrations ―Many analytes present at clinical decision levels ―Eliminates the need for additional low/high level controls at extra expense ―Recommended by ISO 15189 • Many competitors market separate controls for low analyte levels ―This not only increases preparation time but can have significant cost implications “The laboratory should choose concentrations of control materials, wherever possible, especially at or near clinical decision values , which ensure the validity of decisions made” ISO 15189 5.6.2.2
  • 10. Consolidation – Clinically Relevant Levels Comparison of the Randox Immunoassay Premium Plus and a competitors Immunoassay control shows that: • Competitor 1 does not cover the 0.1 uU/ml decision level for TSH. Values are within the normal range 0.4-0.5 • Competitor 1 does not cover the 190pmol/l decision level for Vitamin B12 • Ferritin levels in the Competitor 1 level 1 control are too high • Competitor 1 does not cover the 3mIU/l decision level for insulin
  • 11. Consolidation – Clinically Relevant Levels The Liquid Chemistry Premium Plus control contains high levels of CRP and other proteins eliminating the need for a separate protein control.
  • 12. Consolidation – Clinically Relevant Levels • New high sensitivity troponin assays allow for earlier detection of troponin in the blood allowing for early rule out • Demand for lower troponin levels to ensure accurate instrument performance at such highly sensitive levels Randox L1 Competitor L1 Analyte Units 3833CK 3909CK 3910CK Mean Analyte Units 29831 29841 29851Mean Troponin I ng/ml 0.089 0.03 0.086 0.07Troponin I ng/ml 1.21 1.76 0.68 1.22
  • 13. Cost Effective – Consolidation Competitor Randox Chemistry Control Assayed Chemistry Premium Plus Immunology Control Competitor Randox Immunoassay Control Immunoassay Premium Plus Tumour Marker Control 1 Immunoassay Speciality Tumour Marker Control 2 Speciality Control Vitamin D Control Anti-TPO Control Low Testosterone Control 9 competitor controls consolidated to just 3 Randox controls
  • 14. Cost Effective – Consolidation Competitor Controls Randox Controls Chemistry Control Level 1 Assayed Chemistry Premium Plus Control L2 Chemistry Control Level 2 Assayed Chemistry Premium Plus Control L3 Immunology Control Level 1 Custom RF + CRP Control Immunology Control Level 3 Bile Acids Control Level 1 Bile Acids Control Level 2 Lipid Control Level 1 Lipid Control Level 3 Troponin Level 1 Troponin Level 2 Competitor Controls Randox Controls Anaemia Control Level 1 Immunoassay Premium Plus L1 Anaemia Control Level 2 Immunoassay Premium Plus L3 Tumour Marker Control Level 1 Tumour Marker Control Level 2 TDM Control Level 1 TDM Control Level 2 16 competitor controls consolidated to just 5 Randox controls
  • 15. High Quality • Accurate target values ― Unique value assignment process employing over 40,000 independent labs ― Ensures availability of data for multiple methods and instruments ― Statistically valid ― Unlike some competitor controls target values won’t shift throughout the shelf life • True third party ― Deliver unbiased performance assessment ― Availability of target values for a wide range of instruments ― Eliminates the need for multiple instrument specific controls ― Recommended by ISO 15189 • Commutable ― QC samples will behave in the same manner as the patient sample ― 100% human samples for immunoassay methods eliminating QC shifts when reagent batch is changed ― Vital when validating new batches of reagent ― Ensures minimal lot to lot variation ― Recommended by ISO 15189 Ensure complete confidence in routine testing
  • 16. Benefits of commutability • Most labs will be experiencing shifts in QC target values when they change batch of reagent – especially with Immunoassay tests • By using a commutable control laboratories could - Reduce the need to re-assign QC target values when reagent batch is used - Reduce labour - Reduce costs of QC - Reduce reagent wastage - Reduce troubleshooting - Improve confidence that test system is performing accurately - Meet accreditation and regulatory requirements
  • 17. High Quality • Consistent from lot to lot ― Possible due to our superior manufacturing processes and high quality base material ― Target values will not differ significantly between lots ― Stability claims will remain consistent from lot to lot unlike some competitors • Stability ― Shelf life of up to 4 years for lyophilised controls and 2 years for liquid controls ― Ensures continuity of lot supply and reduces costly lot changes and validation studies ― Laboratories can use the same lot of control for longer ― The excellent working stability of our controls will also help to reduce costs and minimise waste • Traceability ― Traceable to international reference materials Ultimately ensures accurate test results with a reduction in costs and time due to fewer re-runs
  • 18. Gain and Maintain ISO Accreditation ISO 15189:2012 Requirements • Commutable controls (Acusera) ― “The laboratory shall use quality control materials that react to the examining system in a manner as close as possible to patient samples” • True third party controls (Acusera) ― “Use of independent third party control materials should be considered, either instead of, or in addition to, any control materials supplied by the reagent or instrument manufacturer” • Clinically significant concentrations (Acusera) ― “The laboratory should choose concentrations of control materials, wherever possible, especially at or near clinical decision values , which ensure the validity of decisions made” • Interlaboratory data management (Acusera 24.7) ― “The laboratory shall have a procedure to prevent the release of patient results in the event of quality control failure. When the quality control rules are violated ………the results shall be rejected and relevant patient samples re-examined” • External Quality Assessment (RIQAS) ― “The laboratory shall participate in an interlaboratory comparison programme(s) (such as an external quality assessment programme or proficiency testing programme)”
  • 19. Flexibility • Extensive analyte menu covering over 350 routine and specialised parameters • Choice of ―Assayed/Unassayed controls ―Liquid/Lyophilised controls ―Human/Bovine controls
  • 20. Assayed Chemistry Premium Plus • Method and instrument specific target values available for 70 analytes ― Includes proteins, immunoassays, lipids, TDMs, cardiac markers, electrophoresis ― Reduces the need for multiple control products • Clinically significant osmolality values ― ~300 mOsm/kg in level 2 and ~ 370 mOSm/kg in level 3 ― Eliminates the need for additional control material • No added preservatives / stabilisers • Excellent working stability ― 7 days at 2oC to 8oC, extended to 4 weeks when stored at -20oC ― Minimises waste and reduces cost • Lyophilised for extended shelf life ― 4 year shelf life means the same lot can be used for longer
  • 21. Immunoassay Premium Plus • Unique 100% human serum matrix ― The material behaves just like a sample patient ― No need to re-assign QC values when reagent batch is changed • Instrument specific target values for 54 analytes ― Including Tumour Markers, Hormones, Therapeutic Drugs and Vitamin D ― Significantly reduces the number of individual immunoassay controls required • Three clinically significant levels available ― Low levels of TSH, Ferritin and Vitamin B12 ― No need to purchase an additional low level control at extra expense • Excellent working stability ― 7 days at 2oC to 8oC, extended to 4 weeks when stored at -20oC ― Minimises waste and reduces cost
  • 22. Specific Protein Control • Contains assayed target values and ranges for 27 serum proteins; including AFP, RF, Free Kappa Light Chain and Free Lambda Light Chain • Liquid ready-to-use requiring no preparation • Open vial stability of 30 days at 2oC to 8oC for all analytes minimises waste and helps to keep costs low • This unique combination of analytes allows for effective consolidation and significant cost savings
  • 23. Liquid Cardiac Control • Contains target values for an impressive 8 different analytes, including Troponin I, Troponin T and D-dimer • Cut off levels for Troponin I and T are in line with internationally recommended levels • No need to purchase a separate control for D-dimer or separate low level controls for Troponin I and T • Liquid ready-to-use requiring no preparation • Open vial stability of 30 days at 2oC to 8oC for all analytes keeps waste to a minimum
  • 24. Summary • Most accurate controls available ― Target values based on data from thousands of independent labs • Most consistent material ― Minimal variation in analyte concentration between lots • Unrivalled stability ― Will meet and often exceed stability claims • Highest quality material ― No added preservatives/stabilisers in our lyophilised material ― Most commutable material • True third party controls ― Provide an unbiased, independent assessment of performance • Consolidation ― Reduce the number of individual controls required